1 Market Overview

1.1 Product Overview and Scope of Human Microbiome

1.2 Classification of Human Microbiome by Type

1.2.1 Overview: Global Human Microbiome Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Human Microbiome Revenue Market Share by Type in 2021

1.2.3 Gastrointestinal Tract Human Micobiome

1.2.4 Urogenital Tract Human Micobiome

1.2.5 Others

1.3 Global Human Microbiome Market by Application

1.3.1 Overview: Global Human Microbiome Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Treatment

1.3.3 Diagnosis

1.4 Global Human Microbiome Market Size & Forecast

1.5 Global Human Microbiome Market Size and Forecast by Region

1.5.1 Global Human Microbiome Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Human Microbiome Market Size by Region, (2017-2022)

1.5.3 North America Human Microbiome Market Size and Prospect (2017-2028)

1.5.4 Europe Human Microbiome Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Human Microbiome Market Size and Prospect (2017-2028)

1.5.6 South America Human Microbiome Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Human Microbiome Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Human Microbiome Market Drivers

1.6.2 Human Microbiome Market Restraints

1.6.3 Human Microbiome Trends Analysis

2 Company Profiles

2.1 Vedanta

2.1.1 Vedanta Details

2.1.2 Vedanta Major Business

2.1.3 Vedanta Human Microbiome Product and Solutions

2.1.4 Vedanta Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Vedanta Recent Developments and Future Plans

2.2 Seres Therapeutics

2.2.1 Seres Therapeutics Details

2.2.2 Seres Therapeutics Major Business

2.2.3 Seres Therapeutics Human Microbiome Product and Solutions

2.2.4 Seres Therapeutics Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Seres Therapeutics Recent Developments and Future Plans

2.3 Second Genome

2.3.1 Second Genome Details

2.3.2 Second Genome Major Business

2.3.3 Second Genome Human Microbiome Product and Solutions

2.3.4 Second Genome Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Second Genome Recent Developments and Future Plans

2.4 Rebiotix

2.4.1 Rebiotix Details

2.4.2 Rebiotix Major Business

2.4.3 Rebiotix Human Microbiome Product and Solutions

2.4.4 Rebiotix Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Rebiotix Recent Developments and Future Plans

2.5 ActoGeniX

2.5.1 ActoGeniX Details

2.5.2 ActoGeniX Major Business

2.5.3 ActoGeniX Human Microbiome Product and Solutions

2.5.4 ActoGeniX Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 ActoGeniX Recent Developments and Future Plans

2.6 Enterome BioScience

2.6.1 Enterome BioScience Details

2.6.2 Enterome BioScience Major Business

2.6.3 Enterome BioScience Human Microbiome Product and Solutions

2.6.4 Enterome BioScience Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Enterome BioScience Recent Developments and Future Plans

2.7 AvidBiotics

2.7.1 AvidBiotics Details

2.7.2 AvidBiotics Major Business

2.7.3 AvidBiotics Human Microbiome Product and Solutions

2.7.4 AvidBiotics Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 AvidBiotics Recent Developments and Future Plans

2.8 4D Pharma Research Ltd

2.8.1 4D Pharma Research Ltd Details

2.8.2 4D Pharma Research Ltd Major Business

2.8.3 4D Pharma Research Ltd Human Microbiome Product and Solutions

2.8.4 4D Pharma Research Ltd Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 4D Pharma Research Ltd Recent Developments and Future Plans

2.9 Enterologics

2.9.1 Enterologics Details

2.9.2 Enterologics Major Business

2.9.3 Enterologics Human Microbiome Product and Solutions

2.9.4 Enterologics Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Enterologics Recent Developments and Future Plans

2.10 Metabogen

2.10.1 Metabogen Details

2.10.2 Metabogen Major Business

2.10.3 Metabogen Human Microbiome Product and Solutions

2.10.4 Metabogen Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Metabogen Recent Developments and Future Plans

2.11 Metabiomics

2.11.1 Metabiomics Details

2.11.2 Metabiomics Major Business

2.11.3 Metabiomics Human Microbiome Product and Solutions

2.11.4 Metabiomics Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Metabiomics Recent Developments and Future Plans

2.12 Ritter Pharmaceuticals

2.12.1 Ritter Pharmaceuticals Details

2.12.2 Ritter Pharmaceuticals Major Business

2.12.3 Ritter Pharmaceuticals Human Microbiome Product and Solutions

2.12.4 Ritter Pharmaceuticals Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Ritter Pharmaceuticals Recent Developments and Future Plans

2.13 Osel

2.13.1 Osel Details

2.13.2 Osel Major Business

2.13.3 Osel Human Microbiome Product and Solutions

2.13.4 Osel Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Osel Recent Developments and Future Plans

2.14 Symberix

2.14.1 Symberix Details

2.14.2 Symberix Major Business

2.14.3 Symberix Human Microbiome Product and Solutions

2.14.4 Symberix Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Symberix Recent Developments and Future Plans

2.15 Miomics

2.15.1 Miomics Details

2.15.2 Miomics Major Business

2.15.3 Miomics Human Microbiome Product and Solutions

2.15.4 Miomics Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Miomics Recent Developments and Future Plans

2.16 Symbiotix Biotherapies

2.16.1 Symbiotix Biotherapies Details

2.16.2 Symbiotix Biotherapies Major Business

2.16.3 Symbiotix Biotherapies Human Microbiome Product and Solutions

2.16.4 Symbiotix Biotherapies Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Symbiotix Biotherapies Recent Developments and Future Plans

2.17 MicroBiome Therapeutics LLC

2.17.1 MicroBiome Therapeutics LLC Details

2.17.2 MicroBiome Therapeutics LLC Major Business

2.17.3 MicroBiome Therapeutics LLC Human Microbiome Product and Solutions

2.17.4 MicroBiome Therapeutics LLC Human Microbiome Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 MicroBiome Therapeutics LLC Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Human Microbiome Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Human Microbiome Players Market Share in 2021

3.2.2 Top 10 Human Microbiome Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Human Microbiome Players Head Office, Products and Services Provided

3.4 Human Microbiome Mergers & Acquisitions

3.5 Human Microbiome New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Human Microbiome Revenue and Market Share by Type (2017-2022)

4.2 Global Human Microbiome Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Human Microbiome Revenue Market Share by Application (2017-2022)

5.2 Global Human Microbiome Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Human Microbiome Revenue by Type (2017-2028)

6.2 North America Human Microbiome Revenue by Application (2017-2028)

6.3 North America Human Microbiome Market Size by Country

6.3.1 North America Human Microbiome Revenue by Country (2017-2028)

6.3.2 United States Human Microbiome Market Size and Forecast (2017-2028)

6.3.3 Canada Human Microbiome Market Size and Forecast (2017-2028)

6.3.4 Mexico Human Microbiome Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Human Microbiome Revenue by Type (2017-2028)

7.2 Europe Human Microbiome Revenue by Application (2017-2028)

7.3 Europe Human Microbiome Market Size by Country

7.3.1 Europe Human Microbiome Revenue by Country (2017-2028)

7.3.2 Germany Human Microbiome Market Size and Forecast (2017-2028)

7.3.3 France Human Microbiome Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Human Microbiome Market Size and Forecast (2017-2028)

7.3.5 Russia Human Microbiome Market Size and Forecast (2017-2028)

7.3.6 Italy Human Microbiome Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Human Microbiome Revenue by Type (2017-2028)

8.2 Asia-Pacific Human Microbiome Revenue by Application (2017-2028)

8.3 Asia-Pacific Human Microbiome Market Size by Region

8.3.1 Asia-Pacific Human Microbiome Revenue by Region (2017-2028)

8.3.2 China Human Microbiome Market Size and Forecast (2017-2028)

8.3.3 Japan Human Microbiome Market Size and Forecast (2017-2028)

8.3.4 South Korea Human Microbiome Market Size and Forecast (2017-2028)

8.3.5 India Human Microbiome Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Human Microbiome Market Size and Forecast (2017-2028)

8.3.7 Australia Human Microbiome Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Human Microbiome Revenue by Type (2017-2028)

9.2 South America Human Microbiome Revenue by Application (2017-2028)

9.3 South America Human Microbiome Market Size by Country

9.3.1 South America Human Microbiome Revenue by Country (2017-2028)

9.3.2 Brazil Human Microbiome Market Size and Forecast (2017-2028)

9.3.3 Argentina Human Microbiome Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Human Microbiome Revenue by Type (2017-2028)

10.2 Middle East & Africa Human Microbiome Revenue by Application (2017-2028)

10.3 Middle East & Africa Human Microbiome Market Size by Country

10.3.1 Middle East & Africa Human Microbiome Revenue by Country (2017-2028)

10.3.2 Turkey Human Microbiome Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Human Microbiome Market Size and Forecast (2017-2028)

10.3.4 UAE Human Microbiome Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Human Microbiome Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Human Microbiome Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Human Microbiome Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Human Microbiome Revenue (USD Million) by Region (2017-2022)

Table 5. Global Human Microbiome Revenue Market Share by Region (2023-2028)

Table 6. Vedanta Corporate Information, Head Office, and Major Competitors

Table 7. Vedanta Major Business

Table 8. Vedanta Human Microbiome Product and Solutions

Table 9. Vedanta Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Seres Therapeutics Corporate Information, Head Office, and Major Competitors

Table 11. Seres Therapeutics Major Business

Table 12. Seres Therapeutics Human Microbiome Product and Solutions

Table 13. Seres Therapeutics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Second Genome Corporate Information, Head Office, and Major Competitors

Table 15. Second Genome Major Business

Table 16. Second Genome Human Microbiome Product and Solutions

Table 17. Second Genome Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Rebiotix Corporate Information, Head Office, and Major Competitors

Table 19. Rebiotix Major Business

Table 20. Rebiotix Human Microbiome Product and Solutions

Table 21. Rebiotix Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. ActoGeniX Corporate Information, Head Office, and Major Competitors

Table 23. ActoGeniX Major Business

Table 24. ActoGeniX Human Microbiome Product and Solutions

Table 25. ActoGeniX Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Enterome BioScience Corporate Information, Head Office, and Major Competitors

Table 27. Enterome BioScience Major Business

Table 28. Enterome BioScience Human Microbiome Product and Solutions

Table 29. Enterome BioScience Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. AvidBiotics Corporate Information, Head Office, and Major Competitors

Table 31. AvidBiotics Major Business

Table 32. AvidBiotics Human Microbiome Product and Solutions

Table 33. AvidBiotics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. 4D Pharma Research Ltd Corporate Information, Head Office, and Major Competitors

Table 35. 4D Pharma Research Ltd Major Business

Table 36. 4D Pharma Research Ltd Human Microbiome Product and Solutions

Table 37. 4D Pharma Research Ltd Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Enterologics Corporate Information, Head Office, and Major Competitors

Table 39. Enterologics Major Business

Table 40. Enterologics Human Microbiome Product and Solutions

Table 41. Enterologics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Metabogen Corporate Information, Head Office, and Major Competitors

Table 43. Metabogen Major Business

Table 44. Metabogen Human Microbiome Product and Solutions

Table 45. Metabogen Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Metabiomics Corporate Information, Head Office, and Major Competitors

Table 47. Metabiomics Major Business

Table 48. Metabiomics Human Microbiome Product and Solutions

Table 49. Metabiomics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Ritter Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 51. Ritter Pharmaceuticals Major Business

Table 52. Ritter Pharmaceuticals Human Microbiome Product and Solutions

Table 53. Ritter Pharmaceuticals Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Osel Corporate Information, Head Office, and Major Competitors

Table 55. Osel Major Business

Table 56. Osel Human Microbiome Product and Solutions

Table 57. Osel Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Symberix Corporate Information, Head Office, and Major Competitors

Table 59. Symberix Major Business

Table 60. Symberix Human Microbiome Product and Solutions

Table 61. Symberix Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Miomics Corporate Information, Head Office, and Major Competitors

Table 63. Miomics Major Business

Table 64. Miomics Human Microbiome Product and Solutions

Table 65. Miomics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Symbiotix Biotherapies Corporate Information, Head Office, and Major Competitors

Table 67. Symbiotix Biotherapies Major Business

Table 68. Symbiotix Biotherapies Human Microbiome Product and Solutions

Table 69. Symbiotix Biotherapies Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. MicroBiome Therapeutics LLC Corporate Information, Head Office, and Major Competitors

Table 71. MicroBiome Therapeutics LLC Major Business

Table 72. MicroBiome Therapeutics LLC Human Microbiome Product and Solutions

Table 73. MicroBiome Therapeutics LLC Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Global Human Microbiome Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 75. Global Human Microbiome Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 76. Breakdown of Human Microbiome by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. Human Microbiome Players Head Office, Products and Services Provided

Table 78. Human Microbiome Mergers & Acquisitions in the Past Five Years

Table 79. Human Microbiome New Entrants and Expansion Plans

Table 80. Global Human Microbiome Revenue (USD Million) by Type (2017-2022)

Table 81. Global Human Microbiome Revenue Share by Type (2017-2022)

Table 82. Global Human Microbiome Revenue Forecast by Type (2023-2028)

Table 83. Global Human Microbiome Revenue by Application (2017-2022)

Table 84. Global Human Microbiome Revenue Forecast by Application (2023-2028)

Table 85. North America Human Microbiome Revenue by Type (2017-2022) & (USD Million)

Table 86. North America Human Microbiome Revenue by Type (2023-2028) & (USD Million)

Table 87. North America Human Microbiome Revenue by Application (2017-2022) & (USD Million)

Table 88. North America Human Microbiome Revenue by Application (2023-2028) & (USD Million)

Table 89. North America Human Microbiome Revenue by Country (2017-2022) & (USD Million)

Table 90. North America Human Microbiome Revenue by Country (2023-2028) & (USD Million)

Table 91. Europe Human Microbiome Revenue by Type (2017-2022) & (USD Million)

Table 92. Europe Human Microbiome Revenue by Type (2023-2028) & (USD Million)

Table 93. Europe Human Microbiome Revenue by Application (2017-2022) & (USD Million)

Table 94. Europe Human Microbiome Revenue by Application (2023-2028) & (USD Million)

Table 95. Europe Human Microbiome Revenue by Country (2017-2022) & (USD Million)

Table 96. Europe Human Microbiome Revenue by Country (2023-2028) & (USD Million)

Table 97. Asia-Pacific Human Microbiome Revenue by Type (2017-2022) & (USD Million)

Table 98. Asia-Pacific Human Microbiome Revenue by Type (2023-2028) & (USD Million)

Table 99. Asia-Pacific Human Microbiome Revenue by Application (2017-2022) & (USD Million)

Table 100. Asia-Pacific Human Microbiome Revenue by Application (2023-2028) & (USD Million)

Table 101. Asia-Pacific Human Microbiome Revenue by Region (2017-2022) & (USD Million)

Table 102. Asia-Pacific Human Microbiome Revenue by Region (2023-2028) & (USD Million)

Table 103. South America Human Microbiome Revenue by Type (2017-2022) & (USD Million)

Table 104. South America Human Microbiome Revenue by Type (2023-2028) & (USD Million)

Table 105. South America Human Microbiome Revenue by Application (2017-2022) & (USD Million)

Table 106. South America Human Microbiome Revenue by Application (2023-2028) & (USD Million)

Table 107. South America Human Microbiome Revenue by Country (2017-2022) & (USD Million)

Table 108. South America Human Microbiome Revenue by Country (2023-2028) & (USD Million)

Table 109. Middle East & Africa Human Microbiome Revenue by Type (2017-2022) & (USD Million)

Table 110. Middle East & Africa Human Microbiome Revenue by Type (2023-2028) & (USD Million)

Table 111. Middle East & Africa Human Microbiome Revenue by Application (2017-2022) & (USD Million)

Table 112. Middle East & Africa Human Microbiome Revenue by Application (2023-2028) & (USD Million)

Table 113. Middle East & Africa Human Microbiome Revenue by Country (2017-2022) & (USD Million)

Table 114. Middle East & Africa Human Microbiome Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Human Microbiome Picture

Figure 2. Global Human Microbiome Revenue Market Share by Type in 2021

Figure 3. Gastrointestinal Tract Human Micobiome

Figure 4. Urogenital Tract Human Micobiome

Figure 5. Others

Figure 6. Human Microbiome Revenue Market Share by Application in 2021

Figure 7. Treatment Picture

Figure 8. Diagnosis Picture

Figure 9. Global Human Microbiome Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Human Microbiome Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Human Microbiome Revenue Market Share by Region (2017-2028)

Figure 12. Global Human Microbiome Revenue Market Share by Region in 2021

Figure 13. North America Human Microbiome Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Human Microbiome Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Human Microbiome Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Human Microbiome Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Human Microbiome Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Human Microbiome Market Drivers

Figure 19. Human Microbiome Market Restraints

Figure 20. Human Microbiome Market Trends

Figure 21. Vedanta Recent Developments and Future Plans

Figure 22. Seres Therapeutics Recent Developments and Future Plans

Figure 23. Second Genome Recent Developments and Future Plans

Figure 24. Rebiotix Recent Developments and Future Plans

Figure 25. ActoGeniX Recent Developments and Future Plans

Figure 26. Enterome BioScience Recent Developments and Future Plans

Figure 27. AvidBiotics Recent Developments and Future Plans

Figure 28. 4D Pharma Research Ltd Recent Developments and Future Plans

Figure 29. Enterologics Recent Developments and Future Plans

Figure 30. Metabogen Recent Developments and Future Plans

Figure 31. Metabiomics Recent Developments and Future Plans

Figure 32. Ritter Pharmaceuticals Recent Developments and Future Plans

Figure 33. Osel Recent Developments and Future Plans

Figure 34. Symberix Recent Developments and Future Plans

Figure 35. Miomics Recent Developments and Future Plans

Figure 36. Symbiotix Biotherapies Recent Developments and Future Plans

Figure 37. MicroBiome Therapeutics LLC Recent Developments and Future Plans

Figure 38. Global Human Microbiome Revenue Share by Players in 2021

Figure 39. Human Microbiome Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 40. Global Top 3 Players Human Microbiome Revenue Market Share in 2021

Figure 41. Global Top 10 Players Human Microbiome Revenue Market Share in 2021

Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 43. Global Human Microbiome Revenue Share by Type in 2021

Figure 44. Global Human Microbiome Market Share Forecast by Type (2023-2028)

Figure 45. Global Human Microbiome Revenue Share by Application in 2021

Figure 46. Global Human Microbiome Market Share Forecast by Application (2023-2028)

Figure 47. North America Human Microbiome Sales Market Share by Type (2017-2028)

Figure 48. North America Human Microbiome Sales Market Share by Application (2017-2028)

Figure 49. North America Human Microbiome Revenue Market Share by Country (2017-2028)

Figure 50. United States Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Canada Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Mexico Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Europe Human Microbiome Sales Market Share by Type (2017-2028)

Figure 54. Europe Human Microbiome Sales Market Share by Application (2017-2028)

Figure 55. Europe Human Microbiome Revenue Market Share by Country (2017-2028)

Figure 56. Germany Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. France Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. United Kingdom Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Russia Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Italy Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Asia-Pacific Human Microbiome Sales Market Share by Type (2017-2028)

Figure 62. Asia-Pacific Human Microbiome Sales Market Share by Application (2017-2028)

Figure 63. Asia-Pacific Human Microbiome Revenue Market Share by Region (2017-2028)

Figure 64. China Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Japan Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South Korea Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. India Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Southeast Asia Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Australia Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. South America Human Microbiome Sales Market Share by Type (2017-2028)

Figure 71. South America Human Microbiome Sales Market Share by Application (2017-2028)

Figure 72. South America Human Microbiome Revenue Market Share by Country (2017-2028)

Figure 73. Brazil Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Argentina Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Middle East and Africa Human Microbiome Sales Market Share by Type (2017-2028)

Figure 76. Middle East and Africa Human Microbiome Sales Market Share by Application (2017-2028)

Figure 77. Middle East and Africa Human Microbiome Revenue Market Share by Country (2017-2028)

Figure 78. Turkey Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Saudi Arabia Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. UAE Human Microbiome Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Methodology

Figure 82. Research Process and Data Source